Please login to the form below

Not currently logged in
Email:
Password:

Senior changes for Virgo Health and Golin health

New roles for Rebecca Rhodes, Ondine Whittington and Sarah Matthew

Virgo Health Golin Health Rebecca Rhodes Ondine Whittington Sarah Matthew

From left: Rebecca Rhodes, Ondine Whittington and Sarah Matthew

Virgo Health's current joint-CEO Sarah Matthew has been appointed to a new role as president of the Golin Global Healthcare Practice.

She will be joined in the role, which encompasses both the Golin and Virgo health brands, by Rebecca Rhodes who's been promoted to chief creative officer.

They will be tasked with expanding the company's global footprint, which now includes additional healthcare expertise acquired via the recent formation of GolinMagic in China.

Meanwhile, Virgo has promoted Ondine Whittington to managing director. She joined the UK-based comms agency in 2006 and has overseen work for some of its biggest clients.

Fred Cook, Golin's CEO, said “This is an exciting time for the Virgo/Golin partnership as it heralds the beginning of a new chapter for our Global Healthcare Practice and I am confident that with Sarah, Rebecca and Ondine in their new roles, they will lead us to achieve our global ambitions”.

Matthew added: “We are delighted to see Ondine appointed to this critical role for Virgo. She is an exceptional practitioner, already trusted and respected by our clients and our team alike. She is exactly the right leader to take Virgo from strength to strength in this exciting new phase.”

Article by
Dominic Tyer

4th February 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The Heart of the Matter 9: Context is King
McCann Complete Medical outlines why multichannel communications - anchored in strong clinical data from journal publications - must not only be transparent, they must also provide a clear clinical context...
Cell and gene therapies: on course for commercial success?
...
eyeforpharma_h_logo.png
Make Anthill your strategic partner in Barcelona
We are excited to attend and exhibit at eyeforpharma Barcelona 2017 (March 14-16th), and present two multichannel strategy workshops....

Infographics